Daratumumab in the treatment of multiple myeloma
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
The current status of CLL treatment
Key topics at the EBMT International Transplant Course 2016
Treating pediatric ALL with chimeric antigen receptor (CAR) T-cell therapy